Insulet Corporation - Common Stock · Transaction Aug 18, 2026 · Filed Sep 10, 2026 · $1,001 to $15,000
XNAS · PODD
0.00% · $0.0000 · Vol Not reported
Market closed · last close shown
Insulet Corporation
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
$140.53
Follow $PODD
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $PODD by emailVeridion Score
BETAHIGH CONF · 6 of 6 factors measuredMon Sep 21 · last completed session · Pre-market · regular session opens 9:30 ET · PODD
MethodologyPODD
Insulet Corporation
Mon Sep 21 · last completed session · Pre-market · regular session opens 9:30 ET
Upper range
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
65/ 100
Veridion Score
Upper range · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6 of 6 factors measured · Mon Sep 21 · last completed session · Pre-market · regular session opens 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is PODD moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Insulet Corporation
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSFounded
2000
Listed
2007
Employees
5K
Country
US
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, more than 600,000 insulin-dependent diabetic patients are using it worldwide.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$140.53
Last session
Day high
$140.53
Last session
Day low
$140.53
Last session
Previous close
$140.53
52W high
$346.36
-59.43% from high
52W low
$131.96
4% of range
Market cap
$9.7B
P/E
33.22×
EPS
$4.23
Beta
-0.26
Shares out
69.4M
Avg volume
1.7M
VWAP
$140.53
Last session
Price history computed in-house
1W
+0.93%
1M
-5.15%
3M
-5.61%
1Y
-58.07%
YTD
-50.56%
SMA 50 $150.25 · below
SMA 200 $200.82 · below
52W position 4%
PODD overview
Related filings and maps
Public disclosures
Congress activity in PODD
Official filing ↗
Insulet Corporation - Common Stock · Transaction May 7, 2026 · Filed May 10, 2026 · $100,001 to $250,000
Insulet Corporation - Common Stock · Transaction Apr 29, 2026 · Filed May 10, 2026 · $100,001 to $250,000
Insulet Corporation - Common Stock · Transaction Apr 4, 2024 · Filed Apr 19, 2024 · $50,001 to $100,000
Insulet Corporation - Common Stock · Transaction Jan 4, 2024 · Filed Aug 12, 2025 · $1,001 to $15,000
Federal contracts
PODD contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for PODD in this window.
Lobbying spend
PODD lobbying filings, year to date.
Registered lobbying filings matched to Insulet Corporation.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for PODD in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for PODD.
Options
Sovereign unlock shows live options positioning for PODD.